We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
featured
Published in Dermatology

Journal Scan / Research · April 23, 2020

Framing Atopic Dermatitis Topical Medication Application Site Discomfort as a Signal of Efficacy Improves Willingness to Continue Use

Journal of the American Academy of Dermatology

 

Additional Info

Disclosure statements are available on the authors' profiles:

Journal of the American Academy of Dermatology
Framing Atopic Dermatitis Topical Medication Application Site Discomfort as a Signal of Efficacy Improves Willingness to Continue Use
J Am Acad Dermatol 2020 Apr 01;[EPub Ahead of Print], AM Bashyam, A Cuellar-Barboza, EJ Masicampo, SR Feldman

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading